arrow_back Back Filing freshness 10-Q FY 2026 SEC EDGAR

MCKESSON CORP

MCK
$1071.99 ▲ +3.09 (+0.29%) at close
Healthcare ·Wholesale-Drugs, Proprietaries & Druggists' Sundries ·USWholesale-Drugs, Proprietaries & Druggists' Sundries
20 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
42
Health
Weak
Moderately Bearish
auto_awesome

Analytical Summary

MCKESSON CORP faces fundamental challenges with weakness in Return on Common Equity (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $132.5B
Dividend Yield 0.30%
Revenue Growth 12.4% ↘
Op. Margin 1.5% ↗
ROIC 117.3% ↗
FCF / Share $46.27 ↗
Trailing P/E 27.8x
Price / Book —
FCF Yield 4.3%
Debt / Equity -3.00
info Valuation on last close. End-of-day price, Nov 5, 2026.

20-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$403.43B
↑ +12.4% —
Net Income Profit after all expenses
$4.76B
↑ +44.5% —
Operating Margin Operating profit as % of sales
1.5%
↑ +25.0% 31th
FCF / Share Free cash flow per share
$46.27
↑ +6.3% —
Long-Term Debt Long-term obligations
$6.53B
↑ +15.4% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑
29
Returns ↓
2
Financial Health →
94
Cash Quality ↓
71

Dividend History

Dividend / share · sourced from SEC filings
$3.17 Latest / share
+15.3% YoY
+11.5% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 20 years · 75 quarters